Last: | $224.23 |
---|---|
Change Percent: | -0.18% |
Open: | $223.23 |
Close: | $224.64 |
High: | $225.385 |
Low: | $220.7 |
Volume: | 303,480 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$224.23 | $223.23 | $224.64 | $225.385 | $220.7 | 303,480 | 04-25-2024 |
$224.64 | $231.19 | $224.64 | $232.25 | $221.9 | 584,504 | 04-24-2024 |
$232.27 | $231.45 | $232.27 | $233.46 | $231.0864 | 381,827 | 04-23-2024 |
$229.89 | $227.66 | $229.89 | $231.55 | $227.605 | 348,338 | 04-22-2024 |
$227.04 | $227.05 | $227.04 | $228.3488 | $226 | 244,270 | 04-19-2024 |
$226.1 | $227.4 | $226.1 | $229.05 | $225.72 | 248,282 | 04-18-2024 |
$226.83 | $229.57 | $226.83 | $229.66 | $226.07 | 405,820 | 04-17-2024 |
$229.25 | $230.44 | $229.25 | $231.11 | $228.57 | 355,764 | 04-16-2024 |
$230.49 | $235.93 | $230.49 | $236.29 | $230.19 | 349,817 | 04-15-2024 |
$232.67 | $233.96 | $232.67 | $235.68 | $231.13 | 377,421 | 04-12-2024 |
$236.25 | $236.19 | $236.25 | $237.8269 | $235.14 | 253,563 | 04-11-2024 |
$236.39 | $239.15 | $236.39 | $240.08 | $236.19 | 340,499 | 04-10-2024 |
$241.58 | $240.1 | $241.58 | $241.9699 | $238.15 | 254,190 | 04-09-2024 |
$238.89 | $239.67 | $238.89 | $240.9099 | $238.49 | 235,932 | 04-08-2024 |
$239.38 | $237.29 | $239.38 | $240.74 | $236.15 | 280,684 | 04-05-2024 |
$236.79 | $241.09 | $236.79 | $242.09 | $235.62 | 334,679 | 04-04-2024 |
$239.29 | $238.85 | $239.29 | $240.8404 | $238.41 | 271,974 | 04-03-2024 |
$239.58 | $240.59 | $239.58 | $240.935 | $238.38 | 281,633 | 04-02-2024 |
$240.87 | $243.76 | $240.87 | $244.11 | $240.86 | 230,194 | 04-01-2024 |
$244.02 | $245.14 | $244.02 | $245.7 | $243.8 | 243,218 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-04-24 12:04:16 ET Revenue growth has been positive due to strong price/cost performance. Despite market challenges, cash flow increased by 6%. Operating expenses decreased, and net income margin slightly declined. Management focused on cost management and risk assessment, with market ris...
First Quarter 2024 Highlights (All comparisons are against the first quarter of 2023 unless otherwise noted) Sales of $801 million, down 5% overall and 6% organically, in line with expectations Reported diluted EPS of $1.60, down 13%, and adjusted diluted EPS of $1.88, down 10%,...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...